Seeking Alpha

Kevin Porter

Kevin Porter
Send Message
View as an RSS Feed
View Kevin Porter's Comments BY TICKER:
Latest  |  Highest rated
  • Enteromedics Garners FDA Approval For Obesity Device: What's Next [View article]
    Unfortunately your data are totally false

    From the FDA official transcript http://1.usa.gov/1lO2gbK

    At least 45% of VBLOC patients achieved at least 25% EWL. This means that more than 45% lost 10% or more weight loss.

    I am not even reporting the data about Qsymia, Contrave and Belviq.
    Total lies by Mr Spencer.
    Jan 26, 2015. 10:02 AM | 1 Like Like |Link to Comment
  • Enteromedics Garners FDA Approval For Obesity Device: What's Next [View article]
    Zero Spin, I reported exactly what he wrote that's VBLOC far exceeds any type of drug therapy

    but you have some very deep issues with anyone who doesn't agree with you, even a director of Bariatric clinic
    Jan 26, 2015. 09:50 AM | Likes Like |Link to Comment
  • Enteromedics Garners FDA Approval For Obesity Device: What's Next [View article]
    You call Stalker and Pumper anyone who doesn't agree with you... you have some serious problems

    Qsymia is the best one.. LOL
    Jan 26, 2015. 09:19 AM | Likes Like |Link to Comment
  • Enteromedics Garners FDA Approval For Obesity Device: What's Next [View article]
    Philip Schauer (director of the Cleveland Clinic’s bariatric and metabolic institute): ''ETRM device’s effect far exceeds any type of drug therapy''.
    He isn't connected to EnteroMedics, unbiased comment.
    Jan 26, 2015. 08:40 AM | 1 Like Like |Link to Comment
  • Is Vivus Headed Towards An Unfortunate Ending? [View article]
    Philip Schauer (director of the Cleveland Clinic’s bariatric institute):
    ''ETRM device’s effect far exceeds any type of drug therapy''.
    He isn't connected to EnteroMedics, unbiased comment.

    Pills longs might want to switch to ETRM, especially considering how low it's priced right now.
    Jan 26, 2015. 08:06 AM | 2 Likes Like |Link to Comment
  • Arena's Sales Pace For Belviq - What Is Needed [View article]
    Philip Schauer (director of the Cleveland Clinic’s bariatric and metabolic institute) :
    ''ETRM device’s effect far exceeds any type of drug therapy''.
    He isn't connected to EnteroMedics, unbiased comment.

    Pills longs might want to switch to ETRM, especially considering how low it's priced right now
    Jan 26, 2015. 08:05 AM | 1 Like Like |Link to Comment
  • Arena's Belviq Prescriptions Fall: More Publicity Is Needed [View article]
    Philip Schauer (director of the Cleveland Clinic’s bariatric and metabolic institute) :
    ''ETRM device’s effect far exceeds any type of drug therapy''.
    He isn't connected to EnteroMedics, unbiased comment.

    Pills longs might want to switch to ETRM, especially considering how low it's priced right now.
    Jan 26, 2015. 08:05 AM | 1 Like Like |Link to Comment
  • Enteromedics Garners FDA Approval For Obesity Device: What's Next [View article]
    If you consider
    * the $$ coming from the options and the warrants
    * the future tax savings from the previous accumulated losses of $250M
    * the technology and the know how
    * the approvals around the world (USA,Europe,Australia, Gulf Region)
    * the patents owned
    * the likely future indications involving this technology

    Any suitor buying out the company for $2.30 (+100% from the last close @ $1.15) is basically paying almost zero.
    Any sell right now in the low $1 is total nonsense.
    Jan 24, 2015. 10:38 AM | 2 Likes Like |Link to Comment
  • Kevin Porter's Realtime 2014 Picks Recap, 5 For 5 [View instapost]
    better but still tough, 5% now
    Jan 23, 2015. 02:52 PM | Likes Like |Link to Comment
  • Kevin Porter's Realtime 2014 Picks Recap, 5 For 5 [View instapost]
    Re ETRM

    Video Interview, Positive VBLOC comments by Dr Dutson UCLA Surgeon

    http://bit.ly/1yRskFV

    ETRM is trading at only 80M cap... that's really ridiculous
    Jan 23, 2015. 09:21 AM | Likes Like |Link to Comment
  • Enteromedics Garners FDA Approval For Obesity Device: What's Next [View article]
    Anything is possible but we are trading at only 80M cap... that's really ridiculous
    Jan 23, 2015. 09:19 AM | 1 Like Like |Link to Comment
  • Enteromedics Garners FDA Approval For Obesity Device: What's Next [View article]
    Video Interview, Positive VBLOC comments by Dr Dutson UCLA Surgeon

    http://bit.ly/1yRskFV
    Jan 23, 2015. 08:10 AM | 2 Likes Like |Link to Comment
  • Enteromedics Garners FDA Approval For Obesity Device: What's Next [View article]
    http://bit.ly/1yUqU0A

    Philip Schauer, director of the Cleveland Clinic’s bariatric and metabolic institute, said the device’s effect “is fairly modest compared to gastric banding and gastric bypass, but far exceeds any type of diet or drug therapy.” He isn't connected to EnteroMedics.

    John Alverdy, a gastrointestinal surgeon at the University of Chicago who isn’t connected to the company, said the device is an early version of the technology, and that treating doctors may be able to make it more effective by tinkering with how it is used. The lasting power of the treatment isn’t clear, he said.

    It is also unclear whether insurers will cover the technology. Dr. Alverdy estimates that, along with the cost of surgery, the new therapy could run $30,000 to $40,000. A spokesman for EnteroMedics said that although the company hasn't set pricing, it expects costs to be competitive with a gastric band device, which can be around $20,000, and gastric bypass surgery which starts around $30,000.
    Jan 22, 2015. 06:52 PM | 2 Likes Like |Link to Comment
  • SDRL Out 10.57 [View instapost]
    Hi, I am still waiting with my 25%. No adding.
    Jan 21, 2015. 11:23 AM | 1 Like Like |Link to Comment
  • Enteromedics Garners FDA Approval For Obesity Device: What's Next [View article]
    Extremely interesting article about ETRM and its future

    http://bit.ly/1GuNFvA

    Next generation of VBLOC will be out, improving both hardware and software

    New targets ETRM is aiming for: pancreatitis, inflammatory bowel disease and other autoimmune disease like that

    In August, a team that included an advisor to Enteromedics showed that stomach cancer growth in mice was suppressed—and the effectiveness of chemotherapy enhanced—by removing the vagus nerve connection.

    A MUST READ
    Jan 21, 2015. 08:52 AM | 2 Likes Like |Link to Comment
COMMENTS STATS
1,934 Comments
3,702 Likes